跳至主要内容
临床试验/NL-OMON45266
NL-OMON45266已完成4 期

Reduced contrast administration in contrast-enhanced spectral mammography (CESM) - Reduced contrast administration in CESM

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
11

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Female patient with histopathogically confirmed invasive breast cancer who recently underwent a clinical CESM exam without complications;
  • 2. Treated with primary surgery;
  • 3. Willing and able to undergo all study procedures;
  • 4. Has personally provided written informed consent.
  • 5. Age * 18

排除标准

  • 1. Pregnancy
  • 2. Allergy for any of the ingredients of (Ultravist) contrast agent
  • 3. Being unable to give informed consent in person
  • 4. History of coronary arterial disease or unstable angina
  • 5. Acute or chronic severe renal insufficiency (glomerular filtration rate < 45 mL/min/1.732)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

已完成
不适用
A phase I, randomised, double-blind, placebo-controlled study in patients with amyotrophic lateral sclerosis to further assess the safety and tolerability of intracerebroventricular administration of sNN0029 infusion solution.ALSLou Gehrig's disease1002930510009720
NL-OMON40611ewron Sweden AB9
已完成
不适用
A phase I randomized, double-blind, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of NPT189 in healthy subjectsAmyloidosis
NL-OMON48151Proclara Biosciences, Inc.24
已完成
2 期
A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders.NMONeuromyelitis optica
NL-OMON46416MedImmune LLC3
已完成
2 期
A randomized, placebo-controlled, double-blind, parallel-group, multi-center, exploratory dose-response study to assess the efficacy and safety of different oral doses of BAY1128688 in women with symptomatic endometriosis over a 12-week treatment periodpain during intercourse ('dyspareunia') and non-cyclic pelvic pain.Well-accepted lay language synomyms for endometriosis are not known to us. Endometriosis describes the presence of endometrium elsewhere than in the lining of the uterus. It is associated with pelvic pain during menstruation called 'dysmenorrhea'10038612
NL-OMON46660Bayer5
已完成
不适用
A randomized prospective clinical trial comparing OsteoActivator-P coated membranes vs Collagen Membrane-P uncoated for accelerated localized alveolar ridge preservation.dentaalloss of bone volume
NL-OMON51997Osteo-Pharma.B.V.16